At one year, the drug met its primary and all key secondary endpoints, delivering significantly better weight maintenance than placebo
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
This recognition demonstrate excellence in intellectual property (IP) value creation.
The move strengthens GBL’s clinical-stage presence in the United States
Patients with BRCA mutations often face aggressive disease and poor prognosis
India plays a critical role in Bristol Myers Squibb’s global strategy
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
Subscribe To Our Newsletter & Stay Updated
